Regulatory News
Monday, June 6, 2016
BRIEF-Cara Therapeutics resumes patient recruitment
* Resumed patient recruitment after FDA removed clinical
hold on CLIN3001 adaptive phase 3 trial of I.V. CR845 for
postoperative pain
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment